Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04142073 · ClinicalTrials.gov registry record
CCU Wireless Vital Signs Monitoring
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 30
- Enrollment target
NCT04142073: Completed study, sponsored by Northwestern University.
NCT04142073 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04142073 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a pilot study is to test a wireless, skin-sensor device against current technology in the CCU to monitor vitals
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2019-04-16 |
| Est. Completion | 2023-06-30 |
What the finished NCT04142073 record still lists
NCT04142073 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 30 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT04142073 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04142073 about?
NCT04142073 is a clinical study titled "CCU Wireless Vital Signs Monitoring". This is a pilot study is to test a wireless, skin-sensor device against current technology in the CCU to monitor vitals
What is the current status of trial NCT04142073?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2019-04-16. Estimated completion is 2023-06-30.
Who is sponsoring clinical trial NCT04142073?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI